67.52  -0.93 (-1.36%)		09-17 14:17
Open: 69.445 High: 70.795 Volume: 391,444		Pre. Close: 68.45 Low: 67.51 Market Cap: 6,004(M)

Short term
Mid term
Targets	6-month :	86.39	1-year :	94.4
Resists	First :	73.96	Second :	80.83
Pivot price	68.02
Supports	First :	62.86	Second :	52.29
MAs	MA(5) :	67.2	MA(20) :	68.6
	MA(100) :	69.03	MA(250) :	47.28
MACD	MACD :	-2.5	Signal :	-2.9
%K %D	K(14,3) :	54	D(3) :	31.7
RSI	RSI(14): 47.2
52-week	High :	93.61	Low :	21.14

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ LQDA ] has closed below upper band by 17.0%. Bollinger Bands are 67.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	69.99 - 70.32	70.32 - 70.63
Low:	64.54 - 64.92	64.92 - 65.26
Close:	67.81 - 68.45	68.45 - 69.02

Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.

Wed, 16 Sep 2026
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus

Wed, 16 Sep 2026
Liquidia Jumps 5.3% Amid Sector-Wide Rally - AlphaStreet

Wed, 16 Sep 2026
Liquidia (NASDAQ:LQDA) Trading Up 6% - Still a Buy? - MarketBeat

Tue, 15 Sep 2026
Raman Singh Sells 8,468 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Tue, 15 Sep 2026
Option exercises and share sales by Liquidia (NASDAQ: LQDA) director - Stock Titan

Tue, 15 Sep 2026
Squarepoint Ops LLC Trims Stock Position in Liquidia Corporation $LQDA - MarketBeat

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	0 (M)
Shares Float	90 (M)
Held by Insiders	6.332e+007 (%)
Held by Institutions	11.3 (%)
Shares Short	12,330 (K)
Shares Short P.Month	0 (K)

EPS	1.6977e+008
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	30.7 %
Operating Margin	49.8 %
Return on Assets (ttm)	27 %
Return on Equity (ttm)	131.8 %
Qtrly Rev. Growth	1 %
Gross Profit (p.s.)	1560.55
Sales Per Share	8.35018e+008
EBITDA (p.s.)	7.72741e+008
Qtrly Earnings Growth	1.3 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	168 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	17.21

Dividend	0
Forward Dividend	1.186e+007
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.